(Bloomberg) -- Catalent Inc. shares rose after the troubled contract drug manufacturer gave investors some reassurance about a slashed fiscal full-year outlook and the third delay to its quarterly ...
A bid by the owner of Wegovy maker Novo Nordisk A/S to buy a key manufacturer presents an opening for the US Federal Trade ...
Pall Corp. (PLL) stock is rising after the company said it will be acquired by Danaher (DHR) for $13.8 billion. Pall Corp. (PLL) stock is rising after the company said it will be acquired by ...
SOMERSET, N.J., May 08, 2024--Catalent, Inc. (NYSE: CTLT) ("Catalent"), the leader in enabling the development and supply of better treatments for patients worldwide, today announced financial ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...
WASHINGTON (AP) — WASHINGTON (AP) — Danaher Corp. (DHR) on Tuesday reported first-quarter profit of $1.09 billion. The Washington-based company said it had net income of $1.45 per share.
Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer ...
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...